![Department of Internal Medicine, 2nd Faculty of Medicine, Charles University and University Hospital Motol - University Hospital in Motol Department of Internal Medicine, 2nd Faculty of Medicine, Charles University and University Hospital Motol - University Hospital in Motol](https://i.ytimg.com/vi/M32IqazCl2w/maxresdefault.jpg)
Department of Internal Medicine, 2nd Faculty of Medicine, Charles University and University Hospital Motol - University Hospital in Motol
Zápis z 22. zasedání výboru České diabetologické společnosti, konaného dne 09 04 2014 od 13,00 hodin, Luhačovi
![Department of Internal Medicine, 2nd Faculty of Medicine, Charles University and University Hospital Motol - University Hospital in Motol Department of Internal Medicine, 2nd Faculty of Medicine, Charles University and University Hospital Motol - University Hospital in Motol](https://www.fnmotol.cz/wp-content/uploads/k5.jpg)
Department of Internal Medicine, 2nd Faculty of Medicine, Charles University and University Hospital Motol - University Hospital in Motol
Zápis z 20. zasedání výboru České diabetologické společnosti, konaného dne 20 02 2018 od 10,00 hodin, Praha 1.
Changes in weight and diabetes compensation (HbA1c) in patients with diabetes mellitus type 2 after adding exenatide (Byetta) to
![PDF) [Changes in weight and diabetes compensation (HbA1c) in patients with diabetes mellitus type 2 after adding exenatide (Byetta) to the current treatment in 28 diabetology departments in the Czech Republic - PDF) [Changes in weight and diabetes compensation (HbA1c) in patients with diabetes mellitus type 2 after adding exenatide (Byetta) to the current treatment in 28 diabetology departments in the Czech Republic -](https://i1.rgstatic.net/publication/236947515_Changes_in_weight_and_diabetes_compensation_HbA1c_in_patients_with_diabetes_mellitus_type_2_after_adding_exenatide_Byetta_to_the_current_treatment_in_28_diabetology_departments_in_the_Czech_Republic_-/links/5648455408ae9f9c13ea20a7/largepreview.png)
PDF) [Changes in weight and diabetes compensation (HbA1c) in patients with diabetes mellitus type 2 after adding exenatide (Byetta) to the current treatment in 28 diabetology departments in the Czech Republic -
![PDF) Dysglycemia and Abnormal Adiposity Drivers of Cardiometabolic-Based Chronic Disease in the Czech Population: Biological, Behavioral, and Cultural/Social Determinants of Health PDF) Dysglycemia and Abnormal Adiposity Drivers of Cardiometabolic-Based Chronic Disease in the Czech Population: Biological, Behavioral, and Cultural/Social Determinants of Health](https://i1.rgstatic.net/publication/353114002_Dysglycemia_and_Abnormal_Adiposity_Drivers_of_Cardiometabolic-Based_Chronic_Disease_in_the_Czech_Population_Biological_Behavioral_and_CulturalSocial_Determinants_of_Health/links/60e7b84d1c28af345856122e/largepreview.png)
PDF) Dysglycemia and Abnormal Adiposity Drivers of Cardiometabolic-Based Chronic Disease in the Czech Population: Biological, Behavioral, and Cultural/Social Determinants of Health
![Department of Internal Medicine, 2nd Faculty of Medicine, Charles University and University Hospital Motol - University Hospital in Motol Department of Internal Medicine, 2nd Faculty of Medicine, Charles University and University Hospital Motol - University Hospital in Motol](https://www.fnmotol.cz/wp-content/uploads/interna-2.jpg)
Department of Internal Medicine, 2nd Faculty of Medicine, Charles University and University Hospital Motol - University Hospital in Motol
![Pavlina PITHOVA | Deputy Head of Department | Doctor of Medicine, Ph.D. | Charles University in Prague, Prague | CUNI | Department of Internal Medicine (2. LF) | Research profile Pavlina PITHOVA | Deputy Head of Department | Doctor of Medicine, Ph.D. | Charles University in Prague, Prague | CUNI | Department of Internal Medicine (2. LF) | Research profile](https://i1.rgstatic.net/ii/profile.image/299292356038663-1448368266332_Q512/Pavlina-Pithova.jpg)